ALBIREO PHARMA, INC. Quarterly Operating Income (Loss) in USD from Q1 2016 to Q3 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Albireo Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q1 2016 to Q3 2022.
  • Albireo Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2022 was -$34.7M, a 11.5% increase year-over-year.
  • Albireo Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2022 was -$123M, a 7.86% increase year-over-year.
  • Albireo Pharma, Inc. annual Operating Income (Loss) for 2021 was -$123M, a 28.3% decline from 2020.
  • Albireo Pharma, Inc. annual Operating Income (Loss) for 2020 was -$96.3M, a 57.5% decline from 2019.
  • Albireo Pharma, Inc. annual Operating Income (Loss) for 2019 was -$61.1M, a 61.3% decline from 2018.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2022 -$123M -$34.7M +$4.52M +11.5% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$127M -$37.2M -$4.17M -12.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-15
Q1 2022 -$123M -$39.6M +$220K +0.55% Jan 1, 2022 Mar 31, 2022 10-Q 2022-05-16
Q4 2021 -$123M -$11.5M +$9.91M +46.3% Oct 1, 2021 Dec 31, 2021 10-K 2022-03-01
Q3 2021 -$133M -$39.2M -$12.1M -44.6% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$121M -$33M -$14.8M -81.3% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15
Q1 2021 -$106M -$39.8M -$10.2M -34.6% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-16
Q4 2020 -$96.3M -$21.4M -$11.6M -117% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-01
Q3 2020 -$84.7M -$27.1M -$6.47M -31.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$78.3M -$18.2M -$2.94M -19.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$75.3M -$29.6M -$14.2M -92.5% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$61.1M -$9.85M +$4.39M +30.8% Oct 1, 2019 Dec 31, 2019 10-K 2021-02-25
Q3 2019 -$65.5M -$20.6M -$7.97M -62.9% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-05
Q2 2019 -$57.5M -$15.3M -$4.87M -46.8% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$52.7M -$15.3M -$14.8M -2542% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$37.9M -$14.2M -$8.9M -167% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-02
Q3 2018 -$29M -$12.7M -$6.13M -93.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$22.9M -$10.4M -$3.8M -57.5% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$19.1M -$581K +$5.52M +90.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q4 2017 -$24.6M -$5.34M +$2.84M +34.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-06
Q3 2017 -$27.4M -$6.53M -$3.1M -90.1% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-08
Q2 2017 -$24.3M -$6.61M -$8.55M -440% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$15.8M -$6.1M -$3.47M -132% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$12.3M -$8.17M Oct 1, 2016 Dec 31, 2016 10-K 2018-03-27
Q3 2016 -$3.44M Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-14
Q2 2016 $1.94M Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-21
Q1 2016 -$2.62M Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.